AXON
Price
$602.46
Change
-$1.32 (-0.22%)
Updated
Apr 28 closing price
Capitalization
46.9B
8 days until earnings call
LGND
Price
$108.88
Change
+$0.81 (+0.75%)
Updated
Apr 28 closing price
Capitalization
2.1B
9 days until earnings call
Ad is loading...

AXON vs LGND

Header iconAXON vs LGND Comparison
Open Charts AXON vs LGNDBanner chart's image
Axon Enterprise
Price$602.46
Change-$1.32 (-0.22%)
Volume$456.13K
Capitalization46.9B
Ligand Pharmaceuticals
Price$108.88
Change+$0.81 (+0.75%)
Volume$84.56K
Capitalization2.1B
AXON vs LGND Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. LGND commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and LGND is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (AXON: $602.46 vs. LGND: $108.88)
Brand notoriety: AXON and LGND are both not notable
AXON represents the Aerospace & Defense, while LGND is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 54% vs. LGND: 67%
Market capitalization -- AXON: $46.9B vs. LGND: $2.1B
AXON [@Aerospace & Defense] is valued at $46.9B. LGND’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $214.19B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $17.26B. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 6 TA indicator(s) are bullish while LGND’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 6 bullish, 2 bearish.
  • LGND’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AXON is a better buy in the short-term than LGND.

Price Growth

AXON (@Aerospace & Defense) experienced а +11.17% price change this week, while LGND (@Biotechnology) price change was +3.88% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +5.19%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was +20.25%.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.96%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -9.88%.

Reported Earning Dates

AXON is expected to report earnings on Aug 12, 2025.

LGND is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Aerospace & Defense (+5.19% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+7.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($46.9B) has a higher market cap than LGND($2.1B). AXON has higher P/E ratio than LGND: AXON (125.51) vs LGND (46.19). LGND YTD gains are higher at: 1.615 vs. AXON (1.370). AXON has higher annual earnings (EBITDA): 437M vs. LGND (40.8M). AXON has more cash in the bank: 986M vs. LGND (256M). LGND has less debt than AXON: LGND (7.11M) vs AXON (722M). AXON has higher revenues than LGND: AXON (2.08B) vs LGND (167M).
AXONLGNDAXON / LGND
Capitalization46.9B2.1B2,234%
EBITDA437M40.8M1,071%
Gain YTD1.3701.61585%
P/E Ratio125.5146.19272%
Revenue2.08B167M1,247%
Total Cash986M256M385%
Total Debt722M7.11M10,162%
FUNDAMENTALS RATINGS
AXON vs LGND: Fundamental Ratings
AXON
LGND
OUTLOOK RATING
1..100
2413
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
1047
SMR RATING
1..100
4790
PRICE GROWTH RATING
1..100
3847
P/E GROWTH RATING
1..100
5590
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LGND's Valuation (77) in the Biotechnology industry is in the same range as AXON (92). This means that LGND’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (10) in the Biotechnology industry is somewhat better than the same rating for LGND (47). This means that AXON’s stock grew somewhat faster than LGND’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for LGND (90). This means that AXON’s stock grew somewhat faster than LGND’s over the last 12 months.

AXON's Price Growth Rating (38) in the Biotechnology industry is in the same range as LGND (47). This means that AXON’s stock grew similarly to LGND’s over the last 12 months.

AXON's P/E Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for LGND (90). This means that AXON’s stock grew somewhat faster than LGND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONLGND
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 15 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
67%
Bearish Trend 22 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
73%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OYRDX24.87N/A
N/A
Invesco Rising Dividends Y
NSDVX20.42N/A
N/A
North Star Dividend I
CIOIX16.73N/A
N/A
Causeway International Opps Inst
RRGSX86.68N/A
N/A
T. Rowe Price Growth Stock R
IMOPX3.44N/A
N/A
Voya MidCap Opportunities Port S2

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
+0.75%
AXON - LGND
49%
Loosely correlated
-0.22%
ACLX - LGND
49%
Loosely correlated
+1.32%
CRNX - LGND
47%
Loosely correlated
+2.22%
DNLI - LGND
45%
Loosely correlated
+3.64%
ROIV - LGND
45%
Loosely correlated
+1.63%
More